Literature DB >> 32733077

Bioactive small secondary metabolites from the mushrooms Lentinula edodes and Flammulina velutipes.

Emi Fukushima-Sakuno1.   

Abstract

Mushrooms have been attracting attention as a source of bioactive compounds for the development of dietary supplements and medicines. Many researchers have reported pharmacological effects of edible mushrooms, and have isolated and identified bioactive substances. Lentinula edodes (shiitake) and Flammulina velutipes (enokitake) are the cultivated edible mushrooms that are popular throughout the world. In L. edodes, polyacetylenes and sulfur compounds have been shown to display antimicrobial activity. In F. velutipes, many types of bioactive terpenes have been reported from mycelium culture filtrate or solid culture substrate. This article reviews the bioactive metabolites of low-molecular weight from L. edodes and F. velutipes.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32733077     DOI: 10.1038/s41429-020-0354-x

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  19 in total

1.  Antibiotic Substances from Basidiomycetes: V. Poria Corticola, Poria Tenuis and an Unidentified Basidiomycete.

Authors:  F Kavanagh; A Hervey; W J Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1950-01       Impact factor: 11.205

2.  Sterol constituents from two edible mushrooms, Lentinula edodes and Tricholoma matsutake.

Authors:  N Ohnuma; K Amemiya; R Kakuda; Y Yaoita; K Machida; M Kikuchi
Journal:  Chem Pharm Bull (Tokyo)       Date:  2000-05       Impact factor: 1.645

3.  Cytotoxic and neuroprotective activities of constituents from Alternaria alternate, a fungal endophyte of Psidium littorale.

Authors:  Jian Xu; Yun-Wei Hu; Wei Qu; Ming-Hua Chen; Liang-Sheng Zhou; Qi-Rui Bi; Jian-Guang Luo; Wen-Yuan Liu; Feng Feng; Jie Zhang
Journal:  Bioorg Chem       Date:  2019-06-06       Impact factor: 5.275

4.  Lanostane triterpenoids from cultivated fruiting bodies of the wood-rot basidiomycete Ganoderma casuarinicola.

Authors:  Masahiko Isaka; Panida Chinthanom; Pranee Rachtawee; Wilunda Choowong; Rattaket Choeyklin; Tuksaporn Thummarukcharoen
Journal:  Phytochemistry       Date:  2019-12-16       Impact factor: 4.072

Review 5.  Are mushrooms medicinal?

Authors:  Nicholas P Money
Journal:  Fungal Biol       Date:  2016-01-21

6.  Lentinacin: a new hypocholesterolemic substance in Lentinus edodes.

Authors:  I Chibata; K Okumura; S Takeyama; K Kotera
Journal:  Experientia       Date:  1969-12-15

7.  Isolation, structure, and synthesis of lenthionine and its analogs.

Authors:  K Morita; S Kobayashi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1967-07       Impact factor: 1.645

8.  Lentysine: a new hypolipidemic agent from a mushroom.

Authors:  T Rokujo; H Kikuchi; A Tensho; Y Tsukitani; T Takenawa; K Yoshida; T Kamiya
Journal:  Life Sci       Date:  1970-04-08       Impact factor: 5.037

Review 9.  Allenic and cumulenic lipids.

Authors:  Valery M Dembitsky; Takashi Maoka
Journal:  Prog Lipid Res       Date:  2007-07-18       Impact factor: 16.195

10.  Eritadenine from Edible Mushrooms Inhibits Activity of Angiotensin Converting Enzyme in Vitro.

Authors:  Sadia Afrin; Md Abdur Rakib; Boh Hyun Kim; Jeong Ok Kim; Yeong Lae Ha
Journal:  J Agric Food Chem       Date:  2016-03-14       Impact factor: 5.279

View more
  3 in total

1.  Ethnomycological Investigation in Serbia: Astonishing Realm of Mycomedicines and Mycofood.

Authors:  Jelena Živković; Marija Ivanov; Dejan Stojković; Jasmina Glamočlija
Journal:  J Fungi (Basel)       Date:  2021-04-29

2.  Untargeted Identification of Alkyne-Containing Natural Products Using Ruthenium-Catalyzed Azide Alkyne Cycloaddition Reactions Coupled to LC-MS/MS.

Authors:  Daniel Back; Brenda T Shaffer; Joyce E Loper; Benjamin Philmus
Journal:  J Nat Prod       Date:  2022-01-19       Impact factor: 4.050

Review 3.  Fungal secondary metabolites in food and pharmaceuticals in the era of multi-omics.

Authors:  Akshay Shankar; Krishna Kant Sharma
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-12       Impact factor: 5.560

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.